Evidence map›Paper›PMID 37800060›Full record

ArticleHeliyon2023

Molecular epidemiological analyses of

Yukitaka Ito, Koichi Tanimoto, Naoko Chiba, Masanobu Otsuka, Masato Ota, Mieko Yoshida, Yusuke Hashimoto, Takahiro Nomura, Haruyoshi Tomita

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yukitaka ItoDivision of Clinical Microbiology Laboratory, Toho University Ohashi Medical Center, Tokyo, Japan.
Koichi TanimotoLaboratory of Bacterial Drug Resistance, Gunma University Graduate School of Medicine, Gunma, Japan.
Naoko ChibaDepartment of Bacteriology, Gunma University Graduate School of Medicine, Gunma, Japan.
Masanobu OtsukaDivision of Clinical Microbiology Laboratory, Toho University Ohashi Medical Center, Tokyo, Japan.
Masato OtaDivision of Clinical Microbiology Laboratory, Toho University Ohashi Medical Center, Tokyo, Japan.
Mieko YoshidaDivision of Clinical Microbiology Laboratory, Toho University Ohashi Medical Center, Tokyo, Japan.
Yusuke HashimotoDepartment of Bacteriology, Gunma University Graduate School of Medicine, Gunma, Japan.
Takahiro NomuraDepartment of Bacteriology, Gunma University Graduate School of Medicine, Gunma, Japan.
Haruyoshi TomitaDepartment of Bacteriology, Gunma University Graduate School of Medicine, Gunma, Japan.
Gunma University · JPToho University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: We performed molecular epidemiological analyses of Methods: Cultured isolates from 919 stool samples from 869 patients obtained from July 2015 to August 2016 were subjected to toxin gene detection, ribotyping, multilocus sequence typing, antimicrobial susceptibility testing, and quantitative real-time polymerase chain reaction testing for Results: Of the 919 stool samples from 869 patients, Conclusions: Major Japanese clonal strains, ST8 and ST17, have been in the hospital environment for a long time and cause healthcare-associated

Indexed as

CD toxinClostridioides difficileHealthcare-associated infectionMolecular epidemiologyRibotyping

Identifiers

PMID37800060
PMCPMC10550568
OpenAlexW4386758924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.